Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy

Several retrospective and a few prospective studies have shown that metastasis-directed therapy (MDT) could delay clinical progression and postpone the initiation of systemic treatment in oligorecurrent prostate cancer (PCa) patients. However, these endpoints are strongly influenced by variables suc...

Descripción completa

Detalles Bibliográficos
Autores principales: Devos, Gaëtan, Berghen, Charlien, Van Eecke, Henri, Stichele, Arthur Vander, Van Poppel, Hendrik, Goffin, Karolien, Mai, Cindy, De Wever, Liesbeth, Albersen, Maarten, Everaerts, Wouter, De Meerleer, Gert, Joniau, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464259/
https://www.ncbi.nlm.nih.gov/pubmed/32823690
http://dx.doi.org/10.3390/cancers12082271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464259/
https://www.ncbi.nlm.nih.gov/pubmed/32823690
http://dx.doi.org/10.3390/cancers12082271

Ejemplares similares